Holden Medical Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.23 Cr
as on 16-11-2024
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.42 Cr
as on 16-11-2024
- Revenue -32.98%
(FY 2023)
- Profit -56.24%
(FY 2023)
- Ebitda -51.51%
(FY 2023)
- Net Worth 0.68%
(FY 2023)
- Total Assets 1.59%
(FY 2023)
About Holden Medical Laboratories
The Corporate was formerly known as Cadland Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.23 Cr.
The company currently has active open charges totaling ₹4.50 Cr. The company has closed loans amounting to ₹1.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sandeep Joshi and Santosh Dube serve as directors at the Company.
- CIN/LLPIN
U24239MH1995PTC085628
- Company No.
085628
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Holden Medical Laboratories Private Limited offer?
Holden Medical Laboratories Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets.
Who are the key members and board of directors at Holden Medical Laboratories?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sandeep Joshi | Director | 01-Aug-2009 | Current |
Santosh Dube | Director | 05-Jun-2019 | Current |
Financial Performance and Corporate Structure Insights of Holden Medical Laboratories.
Holden Medical Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.98% decrease. The company also saw a substantial fall in profitability, with a 56.24% decrease in profit. The company's net worth moved up by a moderate rise of 0.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Holden Medical Laboratories?
In 2023, Holden Medical Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 19 Jan 2015 | ₹4.00 Cr | Open |
Small Industries Development Bank Of India Creation Date: 07 Jun 1996 | ₹5.00 M | Open |
The Thane Janata Sahakari Bank Limited Creation Date: 17 Dec 2011 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Holden Medical Laboratories?
Holden Medical Laboratories has a workforce of 63 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Holden Medical Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Holden Medical Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.